Two ways to teach women about HPV and encourage cervical screening
The Effect of Two Different Health Education Methods on Women's HPV Knowledge, Cervical Cancer Health Belief and Screening Programme.
This project will test whether two kinds of education—motivational-interviewing home visits versus a one-time session with phone reminders—help women aged 30–65 learn more about HPV and go for cervical screening.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 96 (estimated) |
| Ages | 30 Years to 65 Years |
| Sex | Female |
| Sponsor | Saglik Bilimleri Universitesi Gulhane Tip Fakultesi Academic / other |
| Locations | 1 site (Ankara, Kecioren) |
| Trial ID | NCT07017387 on ClinicalTrials.gov |
What this trial studies
Ninety-six literate, married women aged 30–65 registered at Incirli Family Health Center will be randomized into three equal groups. One group receives standard care, one receives three home-based motivational interviewing education sessions plus a brochure, and the other receives a single face-to-face education session with a brochure and two phone reminder calls. Outcomes measured include an HPV Knowledge Scale, a Cervical Cancer and Pap Smear Health Belief Model scale, and a self-assessment VAS, with final follow-up in Week 8. Control-group participants are offered one of the interventions after study completion.
Who should consider this trial
Good fit: Ideal candidates are literate, married women aged 30–65 registered at the Incirli Family Health Center who have not had cervical screening in the past five years and have not completed the HPV vaccine series.
Not a fit: Women who are pregnant or postpartum, have had a hysterectomy, have recent cervical screening within five years, have current cancer or significant hearing/speech/mental disorders, or have received all three HPV vaccine doses are unlikely to benefit from these interventions.
Why it matters
Potential benefit: If successful, the interventions could increase HPV knowledge and raise cervical cancer screening uptake among eligible women.
How similar studies have performed: Previous studies using motivational interviewing and focused health education have shown modest improvements in screening behavior in some settings, but results are mixed depending on population and delivery.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being between 30 and 65 years of age * Being literate * Agreeing to participate in the study * Being female * Being married * Having no history of cervical cancer in first-degree relatives (mother/sister) * Not having undergone cervical cancer screening in the last five years * Not having been diagnosed with cancer Exclusion Criteria: * Being pregnant or in the postpartum period * Having been diagnosed with any type of cancer * Having a hearing or speech impairment, or a mental disorder * Using medication due to psychotic treatments * Having undergone a hysterectomy * Having had cervical cancer screening within the last five years * Having received all three doses of the HPV vaccine
Where this trial is running
Ankara, Kecioren
- Incirli Family Health Center — Ankara, Kecioren, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Serpil Ozdemir, PhD, RN, Associate professor
- Email: serpil.ozdemir@sbu.edu.tr
- Phone: +90 533 451 85 04
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.